The Gingivitis market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Gingivitis pipeline products will significantly revolutionize the Gingivitis market dynamics.
DelveInsight’s “Gingivitis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of Gingivitis, historical and forecasted epidemiology as well as Gingivitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Gingivitis market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
To Know in detail about the Gingivitis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Gingivitis Market Forecast
Some of the key facts of the Gingivitis Market Report:
The Gingivitis Market Size is anticipated to grow with a significant CAGR during the study period (2019-2032).
In April 2025, Scientists at Penn Dental Medicine have created a plant-derived therapy aimed at treating periodontal conditions like gingivitis and periodontitis. This anti-senescence approach, known as “senotherapy,” combines dasatinib, an enzyme inhibitor, with quercetin, a naturally occurring flavonoid compound found in plants.
Globally the prevalence of Gingivitis is common in both developed and developing countries, around 20-50% of the population is affected by Gingivitis
Prevalence of Gingivitis is common among people of age 18-40 years
Over 50% of the adults suffer from Gingivitis on an average of 3 to 4 teeth
The estimated prevalence of Gingivitis in children from age 12-to 15 years was about 29.6%
Key Gingivitis Companies: Procter and Gamble, Colgate Palmolive, GlaxoSmithKline, Amyndas Pharmaceuticals, Biomedical Development Corporation, Rowpar Pharmaceuticals, and others
Key Gingivitis Therapies: Stannous Fluoride Dentifrice, Amine, Stannous fluoride, AMY-101, Iocide Oral Rinse, ClōSYS®, and others
The Gingivitis epidemiology based on gender analyzed that males and females both are equally more affected in the case of Gingivitis
Gingivitis Overview:
Gingivitis is a mild and early stage of gum disease caused by plaque buildup on the teeth. It leads to red, swollen, and bleeding gums, especially during brushing or flossing. Although not usually painful, if left untreated, gingivitis can progress to more severe gum conditions like periodontitis.
Get a Free sample for the Gingivitis Market Report:
https://www.delveinsight.com/report-store/gingivitis-market
Gingivitis Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Gingivitis Epidemiology Segmentation:
The Gingivitis market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:
Total Prevalence of Gingivitis
Prevalent Cases of Gingivitis by severity
Gender-specific Prevalence of Gingivitis
Diagnosed Cases of Episodic and Chronic Gingivitis
Download the report to understand which factors are driving Gingivitis epidemiology trends @ Gingivitis Epidemiological Insights
Gingivitis Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Gingivitis market or expected to get launched during the study period. The analysis covers Gingivitis market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Gingivitis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Gingivitis Therapies and Key Companies
Stannous Fluoride Dentifrice: Procter and Gamble
Amine: Colgate Palmolive
Stannous fluoride: GlaxoSmithKline
AMY-101: Amyndas Pharmaceuticals
Iocide Oral Rinse: Biomedical Development Corporation
ClōSYS®: Rowpar Pharmaceuticals
To know more about Gingivitis treatment, visit @ Gingivitis Medications
Gingivitis Market Drivers
Rising prevalence of gingivitis
Growing oral health awareness
Expansion of OTC and irrigation devices
Technological innovation
Gingivitis Market Barriers
Limited awareness in developing regions
High cost of advanced therapies
Competition with general oral care products
Access and infrastructure issues
Scope of the Gingivitis Market Report
Study Period: 2019–2032
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
Gingivitis Therapeutic Assessment: Gingivitis current marketed and Gingivitis emerging therapies
Gingivitis Market Dynamics: Gingivitis market drivers and Gingivitis market barriers
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
Gingivitis Unmet Needs, KOL’s views, Analyst’s views, Gingivitis Market Access and Reimbursement
Discover more about therapies set to grab major Gingivitis market share @ Gingivitis Treatment Landscape
Table of Contents
1. Report Introduction
2. Executive Summary
3. SWOT analysis
4. Gingivitis Patient Share (%) Overview at a Glance
5. Gingivitis Market Overview at a Glance
6. Gingivitis Disease Background and Overview
7. Gingivitis Epidemiology and Patient Population
8. Country-Specific Patient Population of Gingivitis
9. Gingivitis Current Treatment and Medical Practices
10. Unmet Needs
11. Gingivitis Emerging Therapies
12. Gingivitis Market Outlook
13. Country-Wise Gingivitis Market Analysis (2018–2030)
14. Market Access and Reimbursement of Therapies
15. Gingivitis Market drivers
16. Gingivitis Market barriers
17. Appendix
18. Gingivitis Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
Media ContactCompany Name: DelveInsightContact Person: Gaurav BoraEmail: Send EmailPhone: +14699457679Address:304 S. Jones Blvd #2432City: Las VegasState: NVCountry: United StatesWebsite: https://www.delveinsight.com/
